Boundless Bio, Inc.BOLDNASDAQ
Loading
Year-over-year research & development expense growth
Latest
0.77%
↓ 85% vs avg
Percentile
P54
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
5.05%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.77% |
| Q3 2025 | -12.92% |
| Q2 2025 | -1.95% |
| Q1 2025 | -8.83% |
| Q4 2024 | -5.50% |
| Q3 2024 | -2.63% |
| Q2 2024 | 10.21% |
| Q1 2024 | 26.07% |
| Q4 2023 | -10.57% |
| Q3 2023 | 5.15% |
| Q2 2023 | 16.54% |
| Q1 2023 | -1.60% |
| Q4 2022 | -10.21% |
| Q3 2022 | 0.00% |
| Q3 2019 | 0.90% |
| Q2 2019 | -6.37% |
| Q1 2019 | 41.20% |
| Q4 2018 | -5.70% |
| Q3 2018 | 13.55% |
| Q2 2018 | 32.46% |
| Q1 2018 | -8.21% |
| Q4 2017 | 3.85% |
| Q3 2017 | 11.14% |
| Q2 2017 | 28.72% |
| Q1 2017 | -12.12% |
| Q4 2016 | 32.46% |
| Q3 2016 | 0.00% |